Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

GILD Stock Annual Income Statement. Download in Excel

Gilead Sciences Inc. logo

Gilead Sciences Inc.

Sector: Healthcare   

Industry: Biotechnology

84.67
 
USD
  
-1.47
  
(-1.71%)
Previous close: 86.14  Open: 85.83  Bid: 84.4  Ask: 85.35
52 week range    
62.07   
   87.87
Mkt Cap: 106,086 M  Avg Vol (90 Days): 6,482,176
Peers   
AMGN / 
VRTX / 
ABBV / 
BIIB / 
ILMN / 
MRK / 
PFE / 
JNJ / 
LLY / 
Last updated: Friday 11th October 2024

Stock Rankings

59
MarketXLS Rank
70
Value
61
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

GILD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles33,455 M28,894 M26,454 M
Basic EPS from continuing operations7.9512.3710.083.544.24.240.14.963.664.54
Basic EPS total7.9512.3710.083.544.24.240.14.963.664.54
Basic weighted shares outstanding1,522 M1,464 M1,339 M1,307 M1,298 M1,270 M1,257 M1,256 M1,255 M1,248 M
Cost of sales3,788 M4,006 M4,261 M4,371 M4,853 M4,675 M4,572 M6,601 M5,657 M6,498 M
DevelopmentExpense944 M1,155 M
Diluted EPS total7.3511.919.943.514.174.220.14.933.644.5
Diluted normalized net income/share7.3511.919.943.514.174.220.14.933.644.5
Diluted weighted shares outstanding1,647 M1,521 M1,358 M1,319 M1,308 M1,277 M1,263 M1,262 M1,262 M1,258 M
Dividends paid per share1.291.842.082.282.522.722.842.923.0
Earnings from equity interest-3,618 M-3,725 M-3,814 M
EarningsFromEquityInterestNetOfTax-3,618 M-3,725 M-3,814 M
GainOnSaleOfSecurity21 M67 M57 M
GeneralAndAdministrativeExpense5,246 M5,673 M6,090 M
Gross operating profit21,102 M28,633 M26,129 M21,736 M17,274 M17,774 M20,117 M20,704 M21,624 M20,618 M
Income before tax14,856 M21,659 M17,097 M13,529 M7,799 M5,160 M1,669 M8,278 M5,814 M6,859 M
Income restructuring and M&A-12,928 M-4,508 M527 M
Income taxes2,797 M3,553 M3,609 M8,885 M2,339 M-204 M1,580 M2,077 M1,248 M1,247 M
InterestExpenseNonOperating412 M688 M964 M1,118 M1,077 M995 M984 M1,001 M935 M944 M
MinorityInterests42 M2 M13 M-16 M-5 M22 M34 M24 M26 M52 M
MiscOtherSpecialCharges3 M154 M428 M523 M676 M1,868 M-1,418 M-639 M-581 M198 M
Net income from total operations12,101 M18,108 M13,501 M4,628 M5,455 M5,386 M123 M6,225 M4,592 M5,665 M
NetIncomeCommonStockholders12,101 M18,108 M13,501 M4,628 M5,455 M5,386 M123 M6,225 M4,592 M5,665 M
NetIncomeContinuousOperations12,101 M18,108 M13,501 M4,628 M5,455 M5,386 M123 M6,225 M4,566 M5,612 M
NetNonOperatingInterestIncomeExpense-412 M-688 M-964 M-1,118 M-1,077 M-995 M-984 M-1,001 M-935 M-944 M
Normalized income9,656 M14,078 M-32,205 M8,794 M5,063 M-95 M-4,537 M
Operating income15,265 M22,193 M17,633 M14,124 M9,298 M9,338 M9,927 M9,918 M7,330 M7,605 M
Operating income before depreciation (EBITDA)16,318 M23,445 M19,219 M15,933 M10,305 M7,559 M4,133 M11,329 M8,852 M10,496 M
OperatingExpense5,837 M6,440 M8,496 M7,612 M-7,976 M8,436 M10,190 M10,786 M11,594 M12,963 M
Other income net-3 M-154 M-428 M-523 M422 M3,183 M7,274 M639 M-4,225 M-1,007 M
Other special charges-1,098 M-5,051 M-5,856 M
OtherGandA5,246 M5,673 M6,090 M
OtherImpairmentOfCapitalAssets2,700 M50 M
OtherOperatingExpenses-147 M-129 M-265 M
PromotionAndAdvertising735 M778 M826 M
Research & development expense2,854 M3,014 M5,098 M3,734 M-3,920 M4,055 M5,039 M5,540 M5,921 M6,873 M
ResearchExpense5,540 M4,977 M5,718 M
RestructringAndMnAIncome-12,928 M-4,508 M527 M
Revenue per share33,455 M28,894 M26,454 M
SalariesAndWages-100 M-91 M-165 M
Selling Gen & administrative expense2,983 M3,426 M3,398 M3,878 M4,056 M4,381 M5,151 M5,246 M5,673 M6,090 M
SellingAndMarketingExpense735 M778 M826 M
Special income/charges-1,098 M-5,051 M-5,856 M-527 M
Total Income available for interest expense (EBIT)15,268 M22,347 M18,061 M14,647 M8,876 M6,155 M2,653 M9,279 M6,749 M7,803 M
Total common shares outstanding1,489 M1,367 M1,307 M1,310 M1,276 M1,264 M1,257 M1,254 M1,247 M1,246 M
Total net income12,101 M18,108 M13,501 M4,628 M5,455 M5,386 M123 M6,225 M4,592 M5,665 M
Total ordinary shares1,245 M1,245 M1,245 M1,245 M1,245 M1,245 M1,245 M1,245 M1,245 M1,245 M
Total revenues24,890 M32,639 M30,390 M26,107 M22,127 M22,449 M24,689 M27,305 M27,281 M27,116 M
TotalExpenses9,625 M10,446 M12,757 M11,983 M13,927 M13,111 M14,762 M17,387 M16,307 M18,306 M
TotalRevenue24,890 M32,639 M30,390 M26,107 M22,127 M22,449 M24,689 M27,305 M27,281 M27,116 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University